Join the club for FREE to access the whole archive and other member benefits.

Amutha Boominathan

Group Lead for the MitoSENS program at SENS Research Foundation

Dr. Boominathan obtained her Ph.D in Biochemistry from the National Chemical Laboratory, India and subsequently had her postdoctoral training at the University of Pennsylvania and Rutgers University.

As an American Heart Association Postdoctoral Fellow, she studied protein import into mitochondria, Fe-S cluster biosynthesis and mechanisms of fusion and fission in mitochondria.

With more than 18 years of experience in mitochondrial biogenesis, she leads a highly motivated team of researchers at SRF in furthering our understanding and developing therapies for myopathies from mitochondrial DNA (mtDNA) mutations.

Visit website: https://www.lifespan.io/dr-amutha-boominathan/

 amutha-boominathan-7aa478213

See also: Institute SENS Research Foundation - Non-profit organization focused on transforming the way the world researches and treats age-related diseases

Details last updated 13-Apr-2020

Amutha Boominathan is also referenced in the following:

Ending Aging Forum 2022

02-Sep-2022 to 03-Sep-2022

Science and Education virtual conference organized by SENS Research Foundation (FREE)

Ending Aging Forum 2023

21-Sep-2023 to 22-Sep-2023

Virtual conference about new rejuvenation biotechnologies organized by SENS Research Foundation (Mountain View, CA, FREE)

Longevity Investors Conference

27-Sep-2021

Online conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth

Amutha Boominathan News

How SENS is tackling mitochondrial DNA damage

How SENS is tackling mitochondrial DNA damage

Lifespan.io (LEAF) - 17-Jan-2020

Amutha Boominathan presented her work on MitoSENS project at Ending Age-Related Diseases 2019